Max Bricchi

Direttore/Membro del Consiglio presso Bial Pharma UK Ltd.

51 anni

Consumer Services

Health Technology

Posizioni attive di Max Bricchi

Società	Posizione	Inizio	Fine
BIAL-Portela & Cia SA BIAL-Portela & Cia SA Pharmaceuticals: MajorHealth Technology BIAL-Portela & Cia SA manufactures pharmaceutical products. It develops drugs in therapeutic areas such as antibiotics, anti-inflammatory, anti-ulcer, anti-depressants, anti-asthmatic, and analgesics. The firm also offers anti-allergic vaccines and the means of diagnosing allergies. It has two production plants and two R&D centers in the Porto area and in Bilbao, Spain. The company was founded by António Portela in 1924 and is headquartered in Coronado, Portugal.	Corporate Officer/Principal	21/04/2023	-
	Direttore/Membro del Consiglio	21/04/2023	-
Bial Pharma UK Ltd.	Direttore/Membro del Consiglio	01/03/2023	-

Universidad de Buenos Aires	Undergraduate Degree
Instituto Tecnológico de Buenos Aires	Graduate Degree
International Institute for Management Development	Masters Business Admin

Distribuzione geografica

Posizioni

Director/Board Member	2
Corporate Officer/Principal	1
Undergraduate Degree	1

Settori

Consumer Services	4
Health Technology	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	2
BIAL-Portela & Cia SA BIAL-Portela & Cia SA Pharmaceuticals: MajorHealth Technology BIAL-Portela & Cia SA manufactures pharmaceutical products. It develops drugs in therapeutic areas such as antibiotics, anti-inflammatory, anti-ulcer, anti-depressants, anti-asthmatic, and analgesics. The firm also offers anti-allergic vaccines and the means of diagnosing allergies. It has two production plants and two R&D centers in the Porto area and in Bilbao, Spain. The company was founded by António Portela in 1924 and is headquartered in Coronado, Portugal.	Health Technology
Bial Pharma UK Ltd.

Aziende private

Health Technology

Bial Pharma UK Ltd.